Cargando…
Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy
Autism spectrum disorders (ASDs) now affect 1–2% of the children born in the United States. Hundreds of genetic, metabolic and environmental factors are known to increase the risk of ASD. Similar factors are known to influence the risk of schizophrenia and bipolar disorder; however, a unifying mecha...
Autores principales: | Naviaux, J C, Schuchbauer, M A, Li, K, Wang, L, Risbrough, V B, Powell, S B, Naviaux, R K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080315/ https://www.ncbi.nlm.nih.gov/pubmed/24937094 http://dx.doi.org/10.1038/tp.2014.33 |
Ejemplares similares
-
Antipurinergic Therapy Corrects the Autism-Like Features in the Poly(IC) Mouse Model
por: Naviaux, Robert K., et al.
Publicado: (2013) -
Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model
por: Naviaux, Jane C, et al.
Publicado: (2015) -
Metabolic and behavioral features of acute hyperpurinergia and the maternal immune activation mouse model of autism spectrum disorder
por: Zolkipli-Cunningham, Zarazuela, et al.
Publicado: (2021) -
A robust, single-injection method for targeted, broad-spectrum plasma metabolomics
por: Li, Kefeng, et al.
Publicado: (2017) -
Improved Dried Blood Spot-Based Metabolomics: A Targeted, Broad-Spectrum, Single-Injection Method
por: Li, Kefeng, et al.
Publicado: (2020)